NDC properties for NDC 9 0003-3764
NDC item 00003376432
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-32 |
| NDC Item | 00003376432 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
NDC item 00003376442
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-42 |
| NDC Item | 00003376442 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
NDC item 00003376474
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-74 |
| NDC Item | 00003376474 |
| packaging | 1 KIT in 1 CARTON (0003-3764-74) * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |